Paxil ANDAs From Alphapharm, Sandoz Receive Final Approval From FDA
This article was originally published in The Pink Sheet Daily
Executive Summary
TorPharm's exclusivity for paroxetine (GlaxoSmithKline's Paxil) comes to an end. FDA had tentatively approved both Alphapharm's and Sandoz' ANDAs.